Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Current Deferred Tax Assets (2020)

Terns Pharmaceuticals' Current Deferred Tax Assets history spans 1 years, with the latest figure at $2.1 million for Q4 2020.

  • For Q4 2020, Current Deferred Tax Assets changed N/A year-over-year to $2.1 million; the TTM value through Dec 2020 reached $2.1 million, changed N/A, while the annual FY2020 figure was $2.1 million, N/A changed from the prior year.
  • Current Deferred Tax Assets reached $2.1 million in Q4 2020 per TERN's latest filing.
  • In the past five years, Current Deferred Tax Assets ranged from a high of $2.1 million in Q4 2020 to a low of $2.1 million in Q4 2020.